Biological model parameter | Value used | Data source | |
HIV biological model parameters | |||
HIV transmission probability per syringe sharing event | 0.14–1.41% | Reference 3 | |
Cofactor increase in HIV transmission probability during | |||
Initial period of high viraemia | 7.5–15 | References 44–46 | |
Pre-AIDS period of high viraemia | 3–6 | Reference 46 | |
Duration of initial period of high viraemia | 1.5–2.5 months | References 46, 47 | |
Duration of pre-AIDS period of high viraemia | 12–24 months | Reference 46 | |
Median duration until severe morbidity or death | 75–92 months | Indian estimates used48 49 | |
Effectiveness of cleaning syringes for disinfecting against HIV (mainly water used) | 52% (37% to 67%)* | Reference 50 | |
HCV biological model parameters | |||
HCV transmission probability if HIV negative | 1.5–14% | See supplementary material3 4 | |
HCV transmission probability if HIV positive relative to if HIV negative | RR 1.0–3.7 | See supplementary material4 33 51 | |
Duration of HCV acute phase of infection | 3–24 months | References 22, 52, 53 | |
Proportion of HCV-infected subjects that resolve infection: | |||
Among HIV negatives | 26% (20% to 50%) | Reference 6 | |
Among HIV positives relative to HIV negatives | RR 0.21–0.58 | References 28, 29, 36, 54 | |
Proportion of resolved infected subjects that become immune: | References 23–25, 27, 35 | ||
If HIV negative | 0–100% | ||
If HIV positive relative to HIV negatives | RR 0.3–0.5 | Few data25 35 | |
Effectiveness of cleaning syringes for disinfecting against HCV (mainly water used) | Assumed same effectiveness as HIV | Few data55 |
HCV, hepatitis C virus; RR, relative risk.
*Effectiveness estimate if rinsed with water.